Viewing StudyNCT00003924



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00003924
Status: UNKNOWN
Last Update Posted: 2013-08-07
First Post: 1999-11-01

Brief Title: Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkins Disease or Non-Hodgkins Lymphoma
Sponsor:
Organization: National Cancer Institute NCI